symp1

0

A. Sytkowski (U.S.A.): Recombinant erythropoietin: structural and functional considerations.

J. Powell (U.S.A.): Cell based gene therapy of erythropoietin results in prolonged stable expression of active erythropoietin using immunoisolation chambers.

I. Macdougall (U.K.): Novel erythopoiesis stimulating protein.

S. Milutinovic (Croatia): Comparative efficacy, safety and pharmacokinetics of erythropoietin alpha and omega. Relation to structural differences?

F. Valderrabano (Spain): Effect of erythropoietin treatment on the quality of life in end-stage renal disease patients.